「肝胆膵消化器病学」は横浜市立大学附属病院の消化器内科部門です

AASLD（米国肝臓学会） Liver Meeting 活動報告

2020-11-28

AASLD（米国肝臓学会） Liver Meeting 活動報告

2020年11月13日～16日にAASLD（米国肝臓学会） Liver Meeting がデジタル形式で開催され，当教室から多数の演題発表がありました．

  1. Takashi Kobayashi, Yuji Ogawa, Satoshi Oeda, Takaomi Kessoku, Michihiro Iwaki, Yasushi Honda, Kento Imajo, Masato Yoneda, Satoru Saito, Hirokazu Takahashi, Atsushi Nakajima.：
    (Ｐｏｓｔｅｒ)A novel three-step algorithm to Predict advanced fibrosis　in non-alcoholic fatty liver disease using FIB-4, ELF test, type IV collagen 7s domain, and vibration-controlled transient elastography.

  2. Michihiro Iwaki, Takaomi Kessoku, Anna Ozaki, Yuki Kasai, Takashi Kobayashi, Asako Nogami, Yasushi Honda, Yuji Ogawa, Kento Imajo, Masato Yoneda, Satoru Saito, Atushi Nakajima. ：
    (Ｐｏｓｔｅｒ)Efficacy of combination therapy with elobixibat and colestyramine for non-alcoholic steatohepatitis model mice to prevent arteriosclerosis.

  3. Takaomi Kessoku, Takashi Kobayashi, Yuki Kasai, Anna Ozaki, Michihiro Iwaki, Yasushi Honda, Yuji Ogawa, Kento Imajo, Shingo Kato, Takuma Higurashi, Masato Yoneda, Kazumi Kubota, Masataka Taguri, Takeharu Yamanaka, Haruki Usada, Koichiro Wada, Satoru Saito, Atsushi Nakajima.：
    (Ｐｏｓｔｅｒ) Efficacy and safety of lubiprostone treatment for non-alcoholic fatty liver disease with advanced fibrosis: A post-hoc analysis of the LUBIPRONE randomized trial.

  4. Kento Imajo, Koki Nagai, Anna Ozaki, Michihiro Iwaki, Takashi Kobayashi, Asako Nogami, Yasushi Honda, Takaomi Kessoku, Yuji Ogawa, Masato Yoneda, Hiroyuki Kirikoshi, Satoru Saito, Atsushi Nakajima. ：
    (Ｐｏｓｔｅｒ)Comparative performance of non-invasive imaging modalities for the diagnosis of NASH　in a Japanese NAFLD population.

  5. Kento Imajo, Koki Nagai, Anna Ozaki, Michihiro Iwaki, Takashi Kobayashi, Asako Nogami, Yasushi Honda, Takaomi Kessoku, Yuji Ogawa, Masato Yoneda, Hiroyuki Kirikosho, Satoru Saito, Atsushi Nakajima. ：
    (Ｐｏｓｔｅｒ)Prospective head-to-head comparison of diagnostic accuracy for staging liver fibrosis among MR elastography, vibration controlled transient elastography and 2-dimention shear-wave elastography　in patients with nonalcoholic fatty liver disease.

  6. Masato Yoneda, Kento Imajo, Yuji Ogawa, Yasushi Honda, Asako Nogami, Takaomi Kessoku, Takashi Kobayashi, Satoru Saito, Atsushi Nakajima. ：
    (Ｐｏｓｔｅｒ)Risk of cardiovascular disease　in patients with nonalcoholic fatty liver disease based on medical big data　in japan.

  7. Nobuyasu Kawamura, Kento Imajo, Kouki Nagai, Anna Ozaki, Michihiro Iwaki, Takashi Kobayashi Asako Nogami, Yasushi Honda, Takaomi Kessoku, Yuji Ogawa, Masato Yoneda, Satoru Saito Kazuhiro Atsukawa, Atsushi Nakajima. ：
    (Ｐｏｓｔｅｒ)Impact of liver stiffness heterogeneity on discordance between pathological liver fibrosis stage and MR elastography-based liver stiffness measurements　in patients with NAFLD.

  8. Suzanne Sharpton, Jeremiah Heilman, Richelle Bettencourt, Kay Pepin, Kathryn Fowler, Claude Sirlin, Egbert Madamba, Jinho Jung, Kento Imajo, Atsushi Nakajima, Richard Ehman, Rohit Loomba. ：
    (Ｏｒａｌ)Diagnostic accuracy of MRI biomarkers cT1 and fat for high-risk non-alcoholic steatohepatitis.

  9. Kathryn Jean Lucas, Patricia Lopez, Eric Lawitz, Aasim Sheikh, Diego Aizenberg, Stanley Hsia, George Boon Bee Goh, John Vierling, Juan Frias, Judith White, Hirokazu Takahashi, Donald Lazas, Masato Yoneda, Salvador Augustin, Won Kim, Juergen Loeffler, Felicity Schaefer, Marilyn Cines, Natasha A Sahr, Sophie Lamle, Miljen Martic, Clifford Brass, and Arun J Sanyal. ：
    (Ｏｒａｌ)Safety and Efficacy of tropifexor　in patients with fibrotic nonalcoholic steatohepatitis: 48-week results from part C of the phase 2 FLIGHT-FXR study.

↑ PAGE TOP